116 Views
Monday Poster Session
Category: Biliary/Pancreas
Chang Li, MD
University of Texas Health Science Center at Houston
Houston, TX, United States
Necrosis, n=12 | No necrosis, n=77 | P value | |
Gender, male; n (%) | 12 (100) | 77 (100) | 1.00 |
Age, years ± sd | 35 ± 10 | 38 ± 9 | 0.76 |
Ethnicity | |||
Hispanic; n (%) | 12 (100) | 64 (83) | 0.20 |
African American; n (%) | 0 (0) | 8 (10) | 0.59 |
Caucasian; n (%) | 0 (0) | 3 (4) | 1.00 |
Other; n (%) | 0 (0) | 2 (3) | 1.00 |
Comorbid conditions | |||
Diabetes mellitus; n (%) | 9 (75) | 56 (73) | 1.00 |
Hgb A1c; % ± sd | 9 ± 3 | 10 ± 3 | 0.32 |
Obesity; n (%) | 8 (67) | 35 (45) | 0.22 |
BMI; kg/m2 ± sd | 32 ± 5 | 30 ± 6 | 0.44 |
Fatty liver disease; n (%) | 2 (17) | 24 (31) | 0.50 |
Alcohol abuse; n (%) | 8 (67) | 42 (55) | 0.54 |
Previous pancreatitis; n (%) | 8 (67) | 33 (43) | 0.21 |
Serum triglyceride levels, mg/dL ± sd | 2013 ± 2231 | 1507 ± 1591 | 0.0065 |
BISAP score; n ± sd | 1 ± 1 | 1 ± 1 | 0.06 |
Ranson’s score at 48 hs; n ± sd | 3 ± 1 | 3 ± 2 | 0.55 |
Hospital length of stay; days ± sd | 7 ± 5 | 5 ± 7 | 0.51 |
Admitted to ICU; n (%) | 7 (58) | 33 (43) | 0.36 |
ICU length of stay; days ± sd | 6 ± 3 | 3 ± 5 | 0.37 |
Treatment received | |||
Insulin; n (%) | 10 (83) | 50 (65) | 0.32 |
Fibrates; n (%) | 8 (67) | 59 (77) | 0.48 |
Complications | |||
Acute kidney injury; n (%) | 6 (50) | 13 (17) | 0.02 |
ARDS; n (%) | 1 (8) | 1 (1) | 0.25 |
Ascites; n (%) | 4 (33) | 8 (10) | 0.05 |
Thrombosis; n (%) | 3 (25) | 3 (4) | 0.03 |
SIRS; n (%) | 11 (92) | 54 (70) | 0.17 |
Pleural effusion; n (%) | 5 (42) | 9 (12) | 0.02 |
Mortality; n (%) | 1 (8) | 0 (0) | 0.13 |